Naren presented his poster last evening on HDAC inhibitors in rhabdomyosarcoma at the 2016 FASEB Satellite Cell meeting in Keystone, Colorado. The poster was well received, and great feedback came from the group. Charles will present this study in a talk on Thursday. 
This work that includes collaboration with our colleague Dr. Chris Vakoc at CSHL was supported by funding from the St. Baldrick’s Foundation, as well as Braver, Stronger, Smarter, as well as the Michelle Paternoster Foundation for Sarcoma Research, the Christina Renna Foundation Inc., the Friends of Doernbecher, the Friends of T.J. Foundation, and the Clarke Gilles Foundation. We are grateful to the families who shared the PDX model data.
